IP Library Granted Patent US 10,463,733
Granted Patent B1
US 10,463,733 · App. 15/440,832 · Granted Nov 5, 2019

Ultra-stable protein ionic liquids

Inventors: Joseph M. Slocik (Dayton, OH); Rajesh R. Naik (Centerville, OH); Patrick B. Dennis (Cincinnati, OH)
Assignee: United States of America as represented by the Secetary of the Air Force
A61K39/39591A61K39/3955A61K47/48215C07K1/10C07K1/36C07K16/00C07K16/34C08G65/00G01N33/531
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,463,733
App. No.
15/440,832
Granted
Nov 5, 2019
Kind
B1
Abstract

A method for creating a stable protein/antibody ionic liquid, comprising: (a) cationizing aqueous proteins/antibodies by addition of an excess of a positively-charged crosslinker in the presence of a coupling reagent; (b) purifying the cationized proteins/antibodies; (c) titrating the cationized proteins/antibodies with a corresponding biologically-compatible counter anionic polymer to create at least one protein/antibody cation/anion pair in aqueous solution until the cation/anion pair solution becomes negative by zeta potential measurement; (d) repeatedly dialyzing the protein/antibody cation/anion pair in water to remove excess anionic polymer using at least one molecular weight cutoff 7000 dialysis membrane; (e) lyophilizing the protein/antibody cation/anion pair to remove most of the water, forming a lyophilized solid; and (f) heating the lyophilized solid until a protein/antibody ionic liquid is generated. The antibody may be any desired antibody, and the anion may be any biologically-compatible anion.

Claims (25)

1. A method for creating water-free ultra-stable antibody ionic liquid, comprising the steps of:

a) providing aqueous anti-hemoglobin antibodies;

b) cationizing aqueous antibodies by adding stoichiometric amounts of N,N-dimethyl-1,3-propanediamine (DMPDA) in the presence of a coupling reagent selected from the group consisting of 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC), succinimidyl iodoacetate (SIA), 2-(dimethylamino) ethanethiol, and N-(p-maleimidophenyl) isocyanate (PMPI);

c) purifying the cationized antibodies by repeated dialysis in water;

d) titrating the cationized antibodies with a counter anionic polymer of poly(ethylene glycol) 4-nonylphenyl 3-sulfopropyl ether (C 9 H 19 C 6 H 4 —(OCH 2 CH 2 ) 20 O(CH 2 ) 3 SO 3 ) to create at least one antibody cation/anion pair in aqueous solution until the antibody cation/anion pair solution becomes negative by zeta potential measurement;

e) dialyzing the antibodies cation/anion pair to remove excess anionic polymer using at least one molecular weight cutoff 7000 dialysis membrane;

f) lyophilizing the at least one antibody cation/anion pair to remove most of the water, forming a lyophilized solid; and

g) heating the lyophilized solid at about 27-50° C. until an antibody ionic liquid is generated.

2. The method for creating a water-free ultra-stable antibody ionic liquid of claim 1 , further comprising:

confirming the cationizing of the aqueous antibodies by measuring a positive zeta potential value.

3. The method for cretin a water-free ultra-stable antibody ionic liquid of claim 1 , further comprising:

confirming the cationizing of the aqueous antibodies by measuring a zeta potential value between about 0 and +5 mV.

4. The method for creating a water-free ultra-stable protein ionic liquid of claim 1 , further comprising:

heating the protein ionic liquid at about 100° C. for about 2 hours;

testing the antibody ionic liquid for antibody recognition of a corresponding antigen.

5. The method for creating a water-fee ultra-stable protein ionic liquid of claim 1 , further comprising:

testing the antibody ionic liquid for antibody recognition of a corresponding antigen using a dot blot assay on a nitrocellulose membrane.

6. A method for creating a water-free ultra-stable antibody ionic liquid, comprising the steps of:

a) providing aqueous anti-hemoglobin antibodies;

b) cationizing aqueous antibodies by adding stoichiometric amounts of N,N-dimethyl-1,3-propanediamine (DMPDA) in the presence of a coupling reagent selected from the group consisting of 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC, succinimidyl iodoacetate (SIA), 2-(dimethylamino) ethanethiol, and N-(p-maleimidophenyl) isocyanate (PMPI),

c) purifying the cationized antibodies by repeated dialysis in water,

d) titrating the cationized antibodies with a counter anionic polymer of poly(ethylene glycol) 4-nonylphenyl 3-sulfopropyl ether (C 9 H 19 C 6 H 4 —(OCH 2 CH 2 )) 20 O(CH 2 ) 3 SO 3 ) to create at least one antibody cation/anion pair in aqueous solution until the antibody cation/anion pair solution becomes negative by zeta potential measurement;

e) dialyzing the antibodies cation/anion pair to remove excess anionic polymer using a dialysis membrane with a molecular weight cutoff of between about 6000-15,000 g/mol;

f) lyophilizing the at least one antibody cation/anion pair to remove most of the water, forming a lyophilized solid; and

g) heating the lyophilized solid at about 27-50° C. until an antibody ionic liquid is generated.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 23, 2017
From: SLOCIK, JOSEPH M, DR; DENNIS, PATRICK B, DR; NAIK, RAJESH R, DR
To: GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE
Reel/Frame 041361/0512 →
Continuity (1)
Provisional Application 62403774 · Oct 4, 2016
Cited By (6)
US 12,233,110 US 12,233,111 US 12,233,112 US 12,337,029 US 12,350,320 US 12,533,315